Jonas Schuhenn

Jonas Schuhenn

Auto-generated profile, based on publicly available information

Jonas Schuhenn

Institute for Virology, University Hospital Essen, University Duisburg-Essen, 45122 Essen, Germany

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 February 2022 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
JSJonas Schuhenn
Jonas Schuhenn
TMToni Luise Meister
Toni Luise Meister
Daniel TodtDaniel Todt
Daniel Todt
TBThilo Bracht
Thilo Bracht
KSKarin Schork
Karin Schork
SPStephanie Pfaender
Stephanie Pfaender
Significance: Type I interferons (IFN-I) exhibit various biological effects during viral infections, and they have been successfully used for clinical treatment of viral diseases. Humans express 12 IFNα subtypes, which strongly differ in their antiviral responses against different viruses. Here we analyzed the antiviral activity of all human IFNα subtypes against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) to identify the underlying immune signatures and explore their therapeutic potential. Our data provide a systemic pattern of antiviral host effector responses mediated by high antiviral IFN-I, which could help to identify key cellular effectors targeted in novel therapeutic approaches against SARS-CoV-2 infection.